Matches in Wikidata for { <http://www.wikidata.org/entity/Q81235555> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q81235555 description "article scientifique (publié 2005)" @default.
- Q81235555 description "artikull shkencor i botuar më 01 janar 2005" @default.
- Q81235555 description "artículu científicu espublizáu en xineru de 2005" @default.
- Q81235555 description "im Januar 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81235555 description "scientific article published on 01 January 2005" @default.
- Q81235555 description "wetenschappelijk artikel" @default.
- Q81235555 description "наукова стаття, опублікована в січні 2005" @default.
- Q81235555 name "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 name "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 name "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 type Item @default.
- Q81235555 label "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 label "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 label "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 prefLabel "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 prefLabel "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 prefLabel "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 P1433 Q81235555-B322196F-5F71-418C-BAF9-3DBC05B5D1C3 @default.
- Q81235555 P1476 Q81235555-E267029C-DBFF-44CD-BC5C-72DA0AC7A3BE @default.
- Q81235555 P2093 Q81235555-67A77853-A0AA-4746-B4D4-9345FF66EB2C @default.
- Q81235555 P2093 Q81235555-6C2E8971-047E-4383-9EFB-7EF6EBA039C1 @default.
- Q81235555 P2093 Q81235555-788C643A-8480-4364-A5E2-DC3F66EB2E6A @default.
- Q81235555 P2093 Q81235555-A02B785D-6ECB-433B-BD30-CFD2B18CFE1F @default.
- Q81235555 P2093 Q81235555-A5CC7AF2-4A33-4B16-9301-D0184A8C9344 @default.
- Q81235555 P2093 Q81235555-C4172DFE-A235-4515-890C-9135E05950E6 @default.
- Q81235555 P2093 Q81235555-C89877D8-A01D-4E27-AD07-6B3CBC4B6B80 @default.
- Q81235555 P2093 Q81235555-E26FA211-624A-492C-A346-D509F0DBCB8E @default.
- Q81235555 P2093 Q81235555-E5117ABE-853A-4FC9-A2F3-D988C1DF8EBF @default.
- Q81235555 P2093 Q81235555-EC28C6D6-8F64-4377-9FBD-4E1AEEE7AE23 @default.
- Q81235555 P304 Q81235555-77697E7C-1A9A-4DEC-9347-5D9E4A5C3C24 @default.
- Q81235555 P31 Q81235555-32AF1E4C-48E8-4CA2-A0FD-F60E2AFE5877 @default.
- Q81235555 P356 Q81235555-47F2F195-28F3-4FF3-8BF5-41024D2FAD33 @default.
- Q81235555 P407 Q81235555-BD627D43-0BFC-49C1-AE4E-ED267C98F849 @default.
- Q81235555 P433 Q81235555-DFD1459B-3118-4B2E-9901-16C9C5862BBA @default.
- Q81235555 P478 Q81235555-352E0397-0822-4BBE-B2A4-D9AE04487D53 @default.
- Q81235555 P577 Q81235555-E7E6EC9A-A39E-4B48-955F-35BD66356C43 @default.
- Q81235555 P698 Q81235555-800E05E8-E62C-48D9-9BB6-64D20E1843E3 @default.
- Q81235555 P921 Q81235555-8FEF9B45-BBAD-4B69-9422-0770738D802A @default.
- Q81235555 P921 Q81235555-97AAF66C-E672-4E8F-A67B-CEE28516514A @default.
- Q81235555 P356 JIMMUNOL.174.2.783 @default.
- Q81235555 P698 15634899 @default.
- Q81235555 P1433 Q3521441 @default.
- Q81235555 P1476 "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation" @default.
- Q81235555 P2093 "Armin Braun" @default.
- Q81235555 P2093 "Barbara Fuchs" @default.
- Q81235555 P2093 "Heinz G Hoymann" @default.
- Q81235555 P2093 "Joerg Zwirner" @default.
- Q81235555 P2093 "Jörg Köhl" @default.
- Q81235555 P2093 "Norbert Krug" @default.
- Q81235555 P2093 "Ralf Baelder" @default.
- Q81235555 P2093 "Thomas Glaab" @default.
- Q81235555 P2093 "Veit Erpenbeck" @default.
- Q81235555 P2093 "Wilfried Bautsch" @default.
- Q81235555 P304 "783-789" @default.
- Q81235555 P31 Q13442814 @default.
- Q81235555 P356 "10.4049/JIMMUNOL.174.2.783" @default.
- Q81235555 P407 Q1860 @default.
- Q81235555 P433 "2" @default.
- Q81235555 P478 "174" @default.
- Q81235555 P577 "2005-01-01T00:00:00Z" @default.
- Q81235555 P698 "15634899" @default.
- Q81235555 P921 Q12301086 @default.
- Q81235555 P921 Q35869 @default.